Behandling af fibrose under anvendelse af FXR-ligander
摘要
The present invention relates to a method for inhibiting fibrosis that occurs in an organ where the farnesoid X receptor (FXR) is expressed. This method involves the step of administering a high potency, activating ligand of FXR in an effective amount to a patient who is not suffering from a cholestatic condition. The invention also provides pharmaceutical compositions containing an effective amount of an FXR ligand and kits for dispensing the pharmaceutical compositions.
申请公布号
DK1734970(T3)
申请公布日期
2015.02.16
申请号
DK20050729394T
申请日期
2005.03.14
申请人
INTERCEPT PHARMACEUTICALS, INC.
发明人
FIORUCCI, STEFANO;PELLICCIARI, ROBERTO;PRUZANSKI, MARK